TrialInvestigational new drugs2019

Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer.

Pedro C Barata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.